
BC Partners-backed Brenntag solidifies IPO plans
BC Partners-backed chemicals distributor Brenntag has released further details on its planned IPO on the Frankfurt stock exchange.
The company plans to place around 30% of its shares at between €46 and €56 and expects to raise between €483m and €588m with the IPO planned for 29 March. Including greenshoe allocation, the company intends to place up to 14.95 million shares, of which up to 10.5 million are from a capital increase.
As reported by unquote" in November 2009, Brenntag restructured its €2.5bn debt pile to prepare itself for the planned IPO. The new terms gave lenders increased interest margins, while allowing Brenntag to use the profits from the IPO to repay subordinated debt before senior tranches.
Brenntag supplies industrial and specialty chemicals to industries in the manufacturing sector. The company is based in Mühlheim an der Ruhr and posted sales of €6.4bn in 2009, employing around 11,000 people.
Deutsche Bank and Goldman Sachs are acting as global coordinators. Additional bookrunners are BofA Merrill Lynch and J P Morgan. Co-lead managers are Commerzbank, HSBC Trinkaus, Société Générale and The Royal Bank of Scotland.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater